Integration of new genetic diseases into statewide newborn screening: New England experience

被引:20
作者
Comeau, AM [1 ]
Larson, C [1 ]
Eaton, RB [1 ]
机构
[1] Univ Massachusetts, Sch Med, New England Newborn Screening Program, Jamaica Plain, MA 02130 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS | 2004年 / 125C卷 / 01期
关键词
newborn screening; newborn screening expansion; tandem mass spectrometry; cystic fibrosis screening;
D O I
10.1002/ajmg.c.30001
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Using a data set of newborn screening specimens tested by the New England Newborn Screening Program (NENSP) between January 1999 and February 2003, we analyzed the number of infants with positive newborn screening results and determined how many positive screening results were due to a recent multiplex expansion of services in some of the states. We found that for the subset of the 4-year cohort for which there was a 233% increase in the number of disorders screened (from 9 to 30 disorders), there was a 31% increase in the number of affected infants identified by the screen. We project that if all states in the program expanded their services and if the incidence of disorders is similar across states, there would be an observed 45% increase in the number of infants detected by the screen and a 43% increase in the number of infants for whom the screening algorithm would require some contact with the infants' health care provider. Furthermore, of those requiring contact, we project a 300% increase in the number of screened-positive infants who would be referred to tertiary care centers for a diagnostic evaluation. Increased contact with the medical community from additions to newborn screening as demonstrated in this report emphasizes the need for an approach in which the newborn screening program assures coordinated communications between birth units, laboratory, primary health care providers, and specialists. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 13 条
[1]   New England Consortium: A model for medical evaluation of expanded newborn screening with tandem mass spectrometry [J].
Albers, S ;
Waisbren, SE ;
Ampola, MG ;
Brewster, TG ;
Burke, LW ;
Demmer, LA ;
Filiano, J ;
Greenstein, RMG ;
Ingham, CL ;
Korson, MS ;
Marsden, D ;
Schwartz, RC ;
Seashore, MR ;
Shih, VE ;
Levy, HL .
JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (02) :303-304
[2]  
Atkinson K, 2001, PUBLIC HEALTH REP, V116, P122, DOI 10.1093/phr/116.2.122
[3]  
COMEAU AM, 2001, IN PRESS PEDIATRICS
[4]   PRELIMINARY REPORT ON A MASS SCREENING-PROGRAM FOR NEONATAL HYPOTHYROIDISM [J].
DUSSAULT, JH ;
COULOMBE, P ;
LABERGE, C ;
LETARTE, J ;
GUYDA, H ;
KHOURY, K .
JOURNAL OF PEDIATRICS, 1975, 86 (05) :670-674
[5]  
GREGG RG, 1993, AM J HUM GENET, V52, P616
[6]  
*MA GEN LEG, PUBL HLTH PROGR COMB, pCH111
[7]  
MACCREADY RA, 1963, NEW ENGL J MED, V269, P52
[8]   TANDEM MASS-SPECTROMETRY - A NEW METHOD FOR ACYLCARNITINE PROFILING WITH POTENTIAL FOR NEONATAL SCREENING FOR INBORN-ERRORS OF METABOLISM [J].
MILLINGTON, DS ;
KODO, N ;
NORWOOD, DL ;
ROE, CR .
JOURNAL OF INHERITED METABOLIC DISEASE, 1990, 13 (03) :321-324
[9]   Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism [J].
Naylor, EW ;
Chace, DH .
JOURNAL OF CHILD NEUROLOGY, 1999, 14 :S4-S8
[10]  
Rashed MS, 1997, CLIN CHEM, V43, P1129